Cargando…
Canonical NFκB signaling in myeloid cells is required for the glioblastoma growth
Tumor development and therapeutic resistance are linked with tumor-associated macrophage (TAM) and myeloid-derived suppressor cell (MDSC) infiltration in tumors via chemokine axis. Chemokine expression, which determines the pro or anti-inflammatory status of myeloid cells, are partly regulated by th...
Autores principales: | Achyut, B. R., Angara, Kartik, Jain, Meenu, Borin, Thaiz F., Rashid, Mohammad H., Iskander, A. S. M., Ara, Roxan, Kolhe, Ravindra, Howard, Shelby, Venugopal, Natasha, Rodriguez, Paulo C., Bradford, Jennifer W., Arbab, Ali S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5653749/ https://www.ncbi.nlm.nih.gov/pubmed/29062041 http://dx.doi.org/10.1038/s41598-017-14079-4 |
Ejemplares similares
-
CXCR2-Expressing Tumor Cells Drive Vascular Mimicry in Antiangiogenic Therapy–Resistant Glioblastoma
por: Angara, Kartik, et al.
Publicado: (2018) -
Changes in the tumor microenvironment and outcome for TME-targeting therapy in glioblastoma: A pilot study
por: Ali, Sehar, et al.
Publicado: (2021) -
HET0016 decreases lung metastasis from breast cancer in immune-competent mouse model
por: Borin, Thaiz F., et al.
Publicado: (2017) -
Major Challenges and Potential Microenvironment-Targeted Therapies in Glioblastoma
por: Arbab, Ali S., et al.
Publicado: (2017) -
Vascular Mimicry: A Novel Neovascularization Mechanism Driving Anti-Angiogenic Therapy (AAT) Resistance in Glioblastoma
por: Angara, Kartik, et al.
Publicado: (2017)